MIBG avidity correlates with clinical features, tumor biology, and outcomes in neuroblastoma: A report from the Children’s Oncology Group

BACKGROUND: Prior studies suggest that neuroblastomas that do not accumulate metaiodobenzyl-guanidine (MIBG) on diagnostic imaging (MIBG non-avid) may have more favorable features compared with MIBG avid tumors. We compared clinical features, biologic features, and clinical outcomes between patients...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Pediatr Blood Cancer
Autores principales: DuBois, Steven G., Mody, Rajen, Naranjo, Arlene, Van Ryn, Collin, Russ, Douglas, Oldridge, Derek, Kreissman, Susan, Baker, David L., Parisi, Marguerite, Shulkin, Barry L., Bai, Harrison, Diskin, Sharon J., Batra, Vandana, Maris, John M., Park, Julie R., Matthay, Katherine K., Yanik, Gregory
Formato: Artigo
Lenguaje:Inglês
Publicado: 2017
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5605392/
https://ncbi.nlm.nih.gov/pubmed/28383813
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.26545
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares